Trial · NCT00436852
Adverse events200
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 200
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Constipation | Gastrointestinal disorders | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 8 | 44 | 8 |
| other | Constipation | Gastrointestinal disorders | Measurable Disease by CT or MRI Scan (ABT-751) | 12 | 47 | 12 |
| other | Anorexia | Metabolism and nutrition disorders | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 7 | 44 | 7 |
| other | Anorexia | Metabolism and nutrition disorders | Measurable Disease by CT or MRI Scan (ABT-751) | 9 | 47 | 9 |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 9 | 44 | 9 |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Measurable Disease by CT or MRI Scan (ABT-751) | 14 | 47 | 14 |
| other | AST: AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 7 | 44 | 7 |
| other | AST: AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Measurable Disease by CT or MRI Scan (ABT-751) | 14 | 47 | 14 |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 0 | 44 | 0 |
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Measurable Disease by CT or MRI Scan (ABT-751) | 12 | 47 | 12 |
| other | Bicarbonate, serum-low | Metabolism and nutrition disorders | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 0 | 44 | 0 |
| other | Bicarbonate, serum-low | Metabolism and nutrition disorders | Measurable Disease by CT or MRI Scan (ABT-751) | 4 | 47 | 4 |
| other | Cholesterol: Cholesterol, serum-high (hypercholestremia) | Investigations | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 0 | 44 | 0 |
| other | Cholesterol: Cholesterol, serum-high (hypercholestremia) | Investigations | Measurable Disease by CT or MRI Scan (ABT-751) | 3 | 47 | 3 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 4 | 44 | 4 |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Measurable Disease by CT or MRI Scan (ABT-751) | 4 | 47 | 4 |
| other | Creatinine | Investigations | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 0 | 44 | 0 |
| other | Creatinine | Investigations | Measurable Disease by CT or MRI Scan (ABT-751) | 4 | 47 | 4 |
| other | Dehydration | Metabolism and nutrition disorders | Disease Evaluable by I-MIBG Scintigraphy (ABT-751) | 4 | 44 | 4 |
| other | Dehydration | Metabolism and nutrition disorders | Measurable Disease by CT or MRI Scan (ABT-751) | 0 | 47 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00436852/events